Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Perrigo Company plc PRGO

Healthcare  —  Drug Manufacturers Specialty & Generic
15.42 0.74 5.04% as of 25 Sep
Market cap
$2.1B
P/E
0.0×
Dividend Champion (10y) Insider Buys (last 12m)
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Perrigo Company plc (PRGO) Business Profile

Updated before January 2025

Company Overview

Perrigo Company plc (PRGO) is a leading global provider of over-the-counter (OTC) health and wellness products. Founded in 1887 by Luther Perrigo in Allegan, Michigan, the company initially focused on repackaging and distributing generic medications. Over the years, Perrigo has evolved into a multinational corporation with a strong presence in the consumer self-care and pharmaceutical markets. Headquartered in Dublin, Ireland, Perrigo operates in more than 30 countries and employs thousands of people worldwide. The company is publicly traded on the New York Stock Exchange under the ticker symbol PRGO.

Perrigo’s leadership team is composed of experienced professionals dedicated to driving innovation and growth. As of recent years, Murray S. Kessler serves as the President and Chief Executive Officer, bringing extensive experience in consumer goods and healthcare industries. Under his leadership, Perrigo has focused on expanding its product portfolio and strengthening its position in the global self-care market.

Core Business Segments

Perrigo operates through two primary business segments: Consumer Self-Care and Prescription Pharmaceuticals. Each segment contributes significantly to the company’s overall revenue and market presence.

1. Consumer Self-Care

This segment is the cornerstone of Perrigo’s business, offering a wide range of OTC health and wellness products. The Consumer Self-Care division is further divided into the following categories:

  • OTC Medications: Perrigo produces private-label and branded OTC medications, including pain relievers, cold and allergy remedies, digestive health products, and smoking cessation aids. Popular products include ibuprofen, acetaminophen, and loratadine-based allergy medications.

  • Vitamins, Minerals, and Supplements (VMS): Perrigo offers a variety of dietary supplements and vitamins, catering to consumers seeking to improve their overall health and wellness.

  • Personal Care Products: This category includes skincare, haircare, and oral care products. Perrigo’s offerings range from sunscreens and moisturizers to toothpaste and mouthwash.

  • Infant Formula and Nutrition: Perrigo is a leading supplier of store-brand infant formula, providing high-quality, affordable alternatives to national brands.

2. Prescription Pharmaceuticals

Perrigo’s Prescription Pharmaceuticals segment focuses on the development and manufacturing of generic prescription drugs. The company specializes in topical medications, including creams, ointments, and gels, as well as oral solid dosage forms. This segment serves healthcare providers and patients by offering cost-effective alternatives to branded prescription medications.

Business Model

Perrigo’s business model revolves around providing high-quality, affordable healthcare products to consumers and healthcare providers. The company achieves this through a combination of in-house manufacturing, strategic partnerships, and a robust distribution network. Perrigo’s private-label products are a key component of its business model, allowing retailers to offer store-brand alternatives to national brands at competitive prices.

Revenue generation is driven by product sales across its Consumer Self-Care and Prescription Pharmaceuticals segments. Perrigo leverages its extensive research and development capabilities to innovate and expand its product portfolio, ensuring it meets the evolving needs of consumers and healthcare providers.

Strategic Direction

Perrigo’s strategic direction is centered on becoming the world’s leading self-care company. To achieve this goal, the company has outlined several key initiatives:

  • Product Innovation: Perrigo is committed to developing new and improved products that address unmet consumer needs. This includes expanding its offerings in the VMS and personal care categories.

  • Geographic Expansion: The company aims to strengthen its presence in emerging markets, where demand for affordable healthcare products is growing.

  • Sustainability Goals: Perrigo is dedicated to reducing its environmental footprint by adopting sustainable manufacturing practices and sourcing materials responsibly.

  • Digital Transformation: The company is investing in digital tools and e-commerce platforms to enhance its customer experience and streamline operations.

Competitive Landscape

Perrigo operates in a highly competitive market, facing competition from both multinational corporations and regional players. Key competitors include:

  • Johnson & Johnson: A global leader in consumer health products, pharmaceuticals, and medical devices.
  • Procter & Gamble: Known for its extensive portfolio of personal care and household products.
  • Reckitt Benckiser: A major player in the health, hygiene, and home product categories.
  • Teva Pharmaceuticals: A leading manufacturer of generic medications.
  • Nestlé: Competes with Perrigo in the infant formula and nutrition segment.

Risk Factors

Perrigo faces several risks that could impact its business operations and financial performance:

  • Market Dependence: The company’s reliance on OTC and generic prescription products makes it vulnerable to changes in consumer preferences and regulatory requirements.
  • Supply Chain Disruptions: Perrigo’s global supply chain is susceptible to disruptions caused by geopolitical events, natural disasters, and pandemics.
  • Regulatory Compliance: The healthcare industry is heavily regulated, and non-compliance with regulations could result in fines, product recalls, or reputational damage.
  • Competition: Intense competition from established players and new entrants could pressure Perrigo’s market share and pricing strategies.

Recent Developments

In recent years, Perrigo has made significant strides in expanding its product portfolio and enhancing its operational efficiency. Notable developments include:

  • Acquisition of HRA Pharma: Perrigo acquired HRA Pharma, a leading provider of consumer healthcare products, to strengthen its position in the self-care market.
  • Launch of New Products: The company introduced several new OTC medications and dietary supplements, catering to the growing demand for health and wellness products.
  • Sustainability Initiatives: Perrigo has implemented measures to reduce its carbon footprint, including energy-efficient manufacturing processes and sustainable packaging solutions.

Investment Considerations

Investors considering Perrigo as a potential investment should weigh the following strengths and risks:

Strengths

  • Strong market position in the OTC and generic pharmaceutical sectors.
  • Diversified product portfolio catering to various consumer needs.
  • Commitment to innovation and sustainability.
  • Global presence with opportunities for growth in emerging markets.

Risks

  • Exposure to regulatory and compliance risks.
  • Dependence on a few key product categories for revenue.
  • Vulnerability to supply chain disruptions and geopolitical uncertainties.

Conclusion

Perrigo Company plc is a prominent player in the global self-care and pharmaceutical markets, offering a diverse range of high-quality, affordable healthcare products. With a strong focus on innovation, sustainability, and geographic expansion, Perrigo is well-positioned to capitalize on the growing demand for self-care solutions. While the company faces challenges such as regulatory compliance and competition, its strategic initiatives and robust business model provide a solid foundation for future growth.